David Chandiwana

561 citations
49 papers · 382 indexed · h-index 12
Topics
Advanced Breast Cancer Therapies (40 papers)HER2/EGFR in Cancer Research (18 papers)Cancer Treatment and Pharmacology (15 papers)

In The Last Decade

David Chandiwana

45 papers receiving 376 citations

Peers

David Chandiwana
Comparison fields: 5 of 48
  • Pulmonary and Respiratory Medicine 278
  • Oncology 231
  • Cancer Research 111
  • Genetics 80
  • Molecular Biology 43
Replace Yong Mun with:
Yong Mun United States
Luigi Cerbone Italy
Vlatka Smoljanović Switzerland
Ekaterina Trishkina Russia
O. Rixe France
Guilherme Harada Brazil
Mark L. Zangardi United States
Alicyn Campbell United States
Luis Paz-Ares Rodríguez Spain
Kaitlyn R. Antonelli United States
David Chandiwana relative to Yong Mun United States Yong Mun's profile →
Citations per field
00.5×3.5×
Yong Mun · 1×
Citations per year

Countries citing papers authored by David Chandiwana

Since Specialization
Citations

This map shows the geographic impact of David Chandiwana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chandiwana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chandiwana more than expected).

Fields of papers citing papers by David Chandiwana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Chandiwana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chandiwana. The network helps show where David Chandiwana may publish in the future.

Co-authorship network of co-authors of David Chandiwana

This figure shows the co-authorship network connecting the top 25 collaborators of David Chandiwana. A scholar is included among the top collaborators of David Chandiwana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Chandiwana. David Chandiwana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 3
4 0
5 1
6 6
7 27
8 0
9 0
10 1
11 2
12 2
13 1
14 1
15 12
16 9
17 9
18 29
19 28
20 1

About David Chandiwana

David Chandiwana is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics, having authored 49 papers that have together received 382 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (40 papers), HER2/EGFR in Cancer Research (18 papers) and Cancer Treatment and Pharmacology (15 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (278 citations), Oncology (231 citations) and Genetics (80 citations). David Chandiwana has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Jinhee Park, Anand A. Dalal, Thomas E. Delea, Howard A. Burris, Santosh Sutradhar, Wolfgang Janni, Joyce O’Shaughnessy, Mario Campone, Sunil Verma and Emilio Alba. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026